| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M A Crocq, D Naber, M H Lader, F Thibaut, M Drici, B Everitt, G C Hall, C Le Jeunne, A Mittoux, J Peuskens, S Priori, M Sturkenboom, S H L Thomas, P Tanghøj, M Toumi, R Mann, N D Moor. Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 12. 2011-08-26. PMID:20926264. |
suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone. |
2011-08-26 |
2023-08-12 |
Not clear |
| M A Crocq, D Naber, M H Lader, F Thibaut, M Drici, B Everitt, G C Hall, C Le Jeunne, A Mittoux, J Peuskens, S Priori, M Sturkenboom, S H L Thomas, P Tanghøj, M Toumi, R Mann, N D Moor. Suicide attempts in a prospective cohort of patients with schizophrenia treated with sertindole or risperidone. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 20. issue 12. 2011-08-26. PMID:20926264. |
the incidence of suicide attempts (fatal and non-fatal) was analysed in a prospective cohort of patients with schizophrenia randomly assigned to sertindole (4905 patients) or risperidone (4904 patients) in a parallel-group open-label study with blinded classification of outcomes (the sertindole cohort prospective study--scop). |
2011-08-26 |
2023-08-12 |
Not clear |
| Gaurav N Kaushi. Re: sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia. Psychopharmacology. vol 215. issue 2. 2011-08-24. PMID:21193982. |
re: sildenafil adjunctive therapy to risperidone in the treatment of the negative symptoms of schizophrenia. |
2011-08-24 |
2023-08-12 |
Not clear |
| Kotaro Hatta, Taro Otachi, Yasuhiko Sudo, Tatsuro Hayakawa, Yuko Ashizawa, Hiroshi Takebayashi, Naoki Hayashi, Hiroshi Hamakawa, Shin Ito, Reiko Nakase, Chie Usui, Hiroyuki Nakamura, Toyoaki Hirata, Yutaka Saw. Difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia. Schizophrenia research. vol 128. issue 1-3. 2011-08-24. PMID:21420283. |
difference in early prediction of antipsychotic non-response between risperidone and olanzapine in the treatment of acute-phase schizophrenia. |
2011-08-24 |
2023-08-12 |
Not clear |
| Cliff McKinney, Kimberly Ren. Atypical antipsychotic medications in the management of disruptive behaviors in children: safety guidelines and recommendations. Clinical psychology review. vol 31. issue 3. 2011-08-23. PMID:21130552. |
however, with exception of using risperidone (i.e., for the management of irritability associated with autism, manic and mixed episodes associated with bipolar i disorder, and schizophrenia) and aripiprazole (i.e., for manic and mixed episodes associated with bipolar i disorder and schizophrenia), the food and drug administration (fda) has not approved the use of aams in children and adolescents. |
2011-08-23 |
2023-08-12 |
Not clear |
| Hua-Lin Cai, Ping-Fei Fang, Huan-De Li, Xiang-Hui Zhang, Li Hu, Wen Yang, Hai-Sen Y. Abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment. Psychiatry research. vol 188. issue 2. 2011-08-09. PMID:21146875. |
abnormal plasma monoamine metabolism in schizophrenia and its correlation with clinical responses to risperidone treatment. |
2011-08-09 |
2023-08-12 |
Not clear |
| Elaine Weiner, Robert R Conley, M Patricia Ball, Stephanie Feldman, James M Gold, Deanna L Kelly, Ikwunga Wonodi, Robert P McMahon, Robert W Buchana. Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 35. issue 11. 2011-08-08. PMID:20664583. |
adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. |
2011-08-08 |
2023-08-12 |
human |
| Ching-Hua Lin, Chao-Chan Kuo, Li-Shiu Chou, Yeng-Hung Chen, Cheng-Chung Chen, Kuo-Hao Huang, Hsien-Yuan Lan. A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814315. |
a randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia. |
2011-08-08 |
2023-08-12 |
Not clear |
| Ching-Hua Lin, Chao-Chan Kuo, Li-Shiu Chou, Yeng-Hung Chen, Cheng-Chung Chen, Kuo-Hao Huang, Hsien-Yuan Lan. A randomized, double-blind comparison of risperidone versus low-dose risperidone plus low-dose haloperidol in treating schizophrenia. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814315. |
this study compared efficacy and safety of risperidone monotherapy versus low-dose risperidone plus low-dose haloperidol in schizophrenia. |
2011-08-08 |
2023-08-12 |
Not clear |
| Rafael Gafoor, Sabine Landau, Tom K J Craig, Thomas Elanjithara, Paddy Power, Philip McGuir. Esquire trial: efficacy and adverse effects of quetiapine versus risperidone in first-episode schizophrenia. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814318. |
esquire trial: efficacy and adverse effects of quetiapine versus risperidone in first-episode schizophrenia. |
2011-08-08 |
2023-08-12 |
Not clear |
| Norio Yasui-Furukori, Hanako Furukori, Norio Sugawara, Akira Fujii, Sunao Kanek. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814333. |
dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. |
2011-08-08 |
2023-08-12 |
Not clear |
| Norio Yasui-Furukori, Hanako Furukori, Norio Sugawara, Akira Fujii, Sunao Kanek. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. Journal of clinical psychopharmacology. vol 30. issue 5. 2011-08-08. PMID:20814333. |
aripiprazole was concomitantly administrated to 16 female patients with schizophrenia receiving 2 to 15 mg/d of risperidone. |
2011-08-08 |
2023-08-12 |
Not clear |
| Pang-Yen Liu, Pei-Chuan Wu, Chun-Yen Chen, Yi-Chyan Che. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome. General hospital psychiatry. vol 33. issue 1. 2011-07-25. PMID:21353143. |
we present the case of a woman with paranoid schizophrenia who was receiving oral risperidone. |
2011-07-25 |
2023-08-12 |
Not clear |
| H Y Meltzer, B W Masse. The role of serotonin receptors in the action of atypical antipsychotic drugs. Current opinion in pharmacology. vol 11. issue 1. 2011-07-25. PMID:21420906. |
there is considerable preclinical and some clinical evidence that effects on 5-ht receptors contribute to the low risk of producing extrapyramidal side effects, which is the defining characteristic of an atypical apd, the lack of elevation in plasma prolactin levels (with risperidone and 9-hydroxyrisperidone being exceptions), antipsychotic action, and ability to improve some domains of cognition in patients with schizophrenia. |
2011-07-25 |
2023-08-12 |
Not clear |
| Maju Mathews, Babatunde Adetunji, Jamal Mahmud, Vinu George, Mathews Thomas, Sunil Josep. Long-acting risperidone in the treatment of schizophrenia: an evidence-based approach. Psychiatry (Edgmont (Pa. : Township)). vol 2. issue 2. 2011-07-14. PMID:21179634. |
long-acting risperidone in the treatment of schizophrenia: an evidence-based approach. |
2011-07-14 |
2023-08-12 |
Not clear |
| Wayne Macfadden, Yi-Wen Ma, J Thomas Haskins, Cynthia A Bossie, Larry Alph. A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia. Psychiatry (Edgmont (Pa. : Township)). vol 7. issue 11. 2011-07-14. PMID:21191530. |
a prospective study comparing the long-term effectiveness of injectable risperidone long-acting therapy and oral aripiprazole in patients with schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| Wayne Macfadden, Yi-Wen Ma, J Thomas Haskins, Cynthia A Bossie, Larry Alph. A Prospective Study Comparing the Long-term Effectiveness of Injectable Risperidone Long-acting Therapy and Oral Aripiprazole in Patients with Schizophrenia. Psychiatry (Edgmont (Pa. : Township)). vol 7. issue 11. 2011-07-14. PMID:21191530. |
to test the hypothesis that long-term maintenance with injectable risperidone long-acting therapy is superior to oral daily aripiprazole in stable patients with schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| R Chandra, H Singh, P K Dalal, O P Asthana, J S Srivastav. Comparative efficacy of centbutindole & risperidone in schizophrenia. Indian journal of psychiatry. vol 44. issue 4. 2011-07-14. PMID:21206602. |
comparative efficacy of centbutindole & risperidone in schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |
| R Chandra, H Singh, P K Dalal, O P Asthana, J S Srivastav. Comparative efficacy of centbutindole & risperidone in schizophrenia. Indian journal of psychiatry. vol 44. issue 4. 2011-07-14. PMID:21206602. |
the findings of present study shows that centbutindole could be used as a promising new drug for treatment of schizophrenia in place of a typical antipsychotics as it has shown improvement on negative symptoms similar to risperidone. |
2011-07-14 |
2023-08-12 |
Not clear |
| Joshua Kantrowitz, Leslie Citrom. Paliperidone: the evidence of its therapeutic value in schizophrenia. Core evidence. vol 2. issue 4. 2011-07-14. PMID:21221191. |
paliperidone, the 9-hydroxy metabolite of risperidone, is a second-generation antipsychotic that was recently approved for the treatment of schizophrenia. |
2011-07-14 |
2023-08-12 |
Not clear |